Mammalian target of rapamycin (mTOR) as a target in human breast cancer cells that have acquired resistance to aromatase inhibitor letrozole

被引：0
|
作者：
Sabnis, Gauri J. [1 ]
Jelovac, Danijela [1 ]
Long, Brian J. [1 ]
Schayowitz, Adam [1 ]
Belosay, Aashvini [1 ]
Brodie, Angela M. H. [1 ]
机构：
[1] Univ Maryland, Sch Med, Baltimore, MD 21201 USA
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2316
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Farnesylthiosalicylic acid blocks mammalian target of rapamycin signaling in breast cancer cells
    Yue, W
    Wang, JP
    Li, YB
    Fan, P
    Santen, RJ
    INTERNATIONAL JOURNAL OF CANCER, 2005, 117 (05) : 746 - 754
  • [32] PML mediates glioblastoma resistance to mammalian target of rapamycin (mTOR)-targeted therapies
    Iwanami, Akio
    Gini, Beatrice
    Zanca, Ciro
    Matsutani, Tomoo
    Assuncao, Alvaro
    Nael, Ali
    Dang, Julie
    Yang, Huijun
    Zhu, Shaojun
    Kohyama, Jun
    Kitabayashi, Issay
    Cavenee, Webster K.
    Cloughesy, Timothy F.
    Furnari, Frank B.
    Nakamura, Masaya
    Toyama, Yoshiaki
    Okano, Hideyuki
    Mischel, Paul S.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (11) : 4339 - 4344
  • [33] Growth inhibition of human breast cancer cells with an iron chelator and a dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor
    Witters, Lois
    Anyanwu, Uchechi
    Nick, Hanspeter
    Hackl, Wolfgang
    Lipton, Allan
    CANCER RESEARCH, 2009, 69
  • [34] Future directions of mammalian target of rapamycin (mTOR) inhibitor therapy in renal cell carcinoma
    Pal, Sumanta Kumar
    Figlin, Robert A.
    TARGETED ONCOLOGY, 2011, 6 (01) : 5 - 16
  • [35] Triggering of Eryptosis, the Suicidal Erythrocyte Death by Mammalian Target of Rapamycin (mTOR) inhibitor Temsirolimus
    Bhuyan, Abdulla Al Mamun
    Cao, Hang
    Lang, Florian
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2017, 42 (04) : 1575 - 1591
  • [36] Future directions of mammalian target of rapamycin (mTOR) inhibitor therapy in renal cell carcinoma
    Sumanta Kumar Pal
    Robert A. Figlin
    Targeted Oncology, 2011, 6 : 5 - 16
  • [37] Mammalian Target of Rapamycin (mTOR) Signalling Pathway-A Potential Target for Cancer Intervention: A Short Overview
    Basnet, Rajesh
    Basnet, Buddha Bahadur
    Gupta, Radheshyam
    Basnet, TilBahadur
    Khadka, Sandhya
    Alam, Md Shan
    CURRENT MOLECULAR PHARMACOLOGY, 2024, 17
  • [38] Mammalian Target of Rapamycin (mTOR) Signalling Pathway-A Potential Target for Cancer Intervention: A Short Overview
    Basnet, Rajesh
    Basnet, Buddha Bahadur
    Gupta, Radheshyam
    Basnet, TilBahadur
    Khadka, Sandhya
    Alam, Md Shan
    CURRENT MOLECULAR PHARMACOLOGY, 2024, 17
  • [39] A phase II trial of a mammalian target of rapamycin inhibitor, temsirolimus, in patients with metastatic breast cancer
    Hahn, O. M.
    Ma, C. X.
    Lin, L.
    Hou, D.
    Sattar, H.
    Olopade, F. O.
    Nanda, R.
    Hoffman, P. C.
    Naughton, M. J.
    Pluard, T.
    Watson, M. A.
    Ellis, M.
    Conzen, S. D.
    Fleming, G. F.
    CANCER RESEARCH, 2009, 69 (02) : 93S - 94S
  • [40] Mammalian target of rapamycin (mTOR) orchestrates the defense program of innate immune cells
    Schmitz, F.
    Heit, A.
    Dreher, S.
    Tittel, K.
    Mages, J.
    Haas, T.
    Krug, A.
    Janssen, K.
    Kirschning, C. V.
    Wagner, H.
    WIENER KLINISCHE WOCHENSCHRIFT, 2008, 120 : 36 - 36
12345